These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28689744)

  • 1. The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer: Methodological issues.
    Safiri S; Ayubi E
    Pancreatology; 2017; 17(5):649. PubMed ID: 28689744
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the letter to the editor regarding "The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer: Methodological issues".
    Ito T; Imai T; Omae K; Sugiura T; Uesaka K
    Pancreatology; 2017; 17(5):650. PubMed ID: 28693975
    [No Abstract]   [Full Text] [Related]  

  • 3. The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer.
    Ito T; Sugiura T; Okamura Y; Yamamoto Y; Ashida R; Aramaki T; Endo M; Uesaka K
    Pancreatology; 2017; 17(3):451-456. PubMed ID: 28298257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of liver magnetic resonance imaging in patients with findings of resectable pancreatic cancer on computed tomography.
    Chew C; O'Dwyer PJ
    Singapore Med J; 2016 Jun; 57(6):334-8. PubMed ID: 27353741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.
    Motosugi U; Ichikawa T; Morisaka H; Sou H; Muhi A; Kimura K; Sano K; Araki T
    Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases.
    Asato N; Tsurusaki M; Sofue K; Hieda Y; Katsube T; Kitajima K; Murakami T
    Jpn J Radiol; 2017 Apr; 35(4):197-205. PubMed ID: 28251499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.
    Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
    J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
    Park MJ; Hong N; Han K; Kim MJ; Lee YJ; Park YS; Rha SE; Park S; Lee WJ; Park SH; Lee CH; Nam CM; An C; Kim HJ; Kim H; Park MS
    Radiology; 2017 Aug; 284(2):423-431. PubMed ID: 28327002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
    Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
    Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
    Schima W; Függer R; Schober E; Oettl C; Wamser P; Grabenwöger F; Ryan JM; Novacek G
    AJR Am J Roentgenol; 2002 Sep; 179(3):717-24. PubMed ID: 12185052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer.
    Kim HW; Lee JC; Paik KH; Kang J; Kim YH; Yoon YS; Han HS; Kim J; Hwang JH
    Surgery; 2017 Jun; 161(6):1579-1587. PubMed ID: 28237643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretin-stimulated multi-detector CT versus mangafodipir trisodium-enhanced MR imaging plus MRCP in characterization of non-metastatic solid pancreatic lesions.
    Boraschi P; Donati F; Gigoni R; Salemi S; Faggioni L; Del Chiaro M; Boggi U; Bartolozzi C; Falaschi F
    Dig Liver Dis; 2009 Nov; 41(11):829-37. PubMed ID: 19303825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer.
    Holzapfel K; Reiser-Erkan C; Fingerle AA; Erkan M; Eiber MJ; Rummeny EJ; Friess H; Kleeff J; Gaa J
    Abdom Imaging; 2011 Apr; 36(2):179-84. PubMed ID: 20563868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Imaging for Colorectal Cancer Metastasis to the Liver: Comparative Effectiveness Research for the Choice of Contrast Agents.
    Seo N; Park MS; Han K; Lee KH; Park SH; Choi GH; Choi JY; Chung YE; Kim MJ
    Cancer Res Treat; 2018 Jan; 50(1):60-70. PubMed ID: 28292007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging.
    Lee DH; Lee JM; Hur BY; Joo I; Yi NJ; Suh KS; Kang KW; Han JK
    Radiology; 2016 Sep; 280(3):782-92. PubMed ID: 27092659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis.
    Vreugdenburg TD; Ma N; Duncan JK; Riitano D; Cameron AL; Maddern GJ
    Int J Colorectal Dis; 2016 Nov; 31(11):1739-1749. PubMed ID: 27682648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer.
    Koelblinger C; Ba-Ssalamah A; Goetzinger P; Puchner S; Weber M; Sahora K; Scharitzer M; Plank C; Schima W
    Radiology; 2011 Jun; 259(3):757-66. PubMed ID: 21436084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.